KRAS and cancer: The five cancer driver pathways with significant enrichment in both SVM-derived coding genes and lncRNA-related genes are KRAS Signaling Up and Down, P53 pathway, IL2/STAT5 signaling, and TNFA signaling via NFKB (Fig. 2a).